HESTERBIONSEHester Biosciences LimitedLowNeutral
Announced Thu, 23 Apr · 14:34 IST

Hester Biosciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

HESTERBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.2%1-day move
₹1493.00
prior close
₹1476.40
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.3+0.4+0.3+0.2+11.3+12.9+13.3+8.8+8.8+22.2+27.6+41.3+58.5
Up moveDown movePending
AI summary

Hester Biosciences has submitted a declaration from Mr. Rajiv Gandhi, acting on behalf of the promoters and promoter group of the company. The disclosure confirms that promoters and the promoter group have NOT created any encumbrance (pledge) on their shareholding, either directly or indirectly, during the Financial Year ended 31 March 2026. This is a negative declaration filed pursuant to Regulation 31(4) of SEBI Takeover Regulations, which requires such confirmation periodically.

Likely market impact

A 'nil' encumbrance declaration is positive for shareholders as it indicates promoters have not pledged their shares, reducing risk of forced selling. This signals financial stability among the promoter group.